Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease

ConclusionFCP could differentiate ASC from mild to moderate patients with UC, but requires validation before clinical use.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research